Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor

Article, Report English OPEN
Mendley, Susan R.; Spyropoulos, Fotios; Counts, Debra R.;
(2015)

We describe an alternative strategy for management of severe growth failure in a 14-year-old child who presented with advanced chronic kidney disease close to puberty. The patient was initially treated with growth hormone for a year until kidney transplantation, followe... View more
  • References (20)
    20 references, page 1 of 2

    Gerson, A. C., Wentz, A., Abraham, A. G., Mendley, S. R., Hooper, S. R., Butler, R. W., Gipson, D. S., Lande, M. B., Shinnar, S., Moxey-Mims, M. M., Warady, B. A., Furth, S. L.. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics. 2010; 125 (2): e349-e357

    Fine, R. N., Kohaut, E., Brown, D., Kuntze, J., Attie, K. M.. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney International. 1996; 49 (3): 781-785

    Numazawa, M., Handa, W., Hasegawa, C., Takahashi, M.. Structure-activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions. Journal of Steroid Biochemistry and Molecular Biology. 2005; 97 (4): 353-359

    Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., Sutter, T.. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochimica et Biophysica Acta—Reviews on Cancer. 2006; 1766 (1): 63-78

    Cavalli, A., Bisi, A., Bertucci, C., Rosini, C., Paluszcak, A., Gobbi, S., Giorgio, E., Rampa, A., Belluti, F., Piazzi, L., Valenti, P., Hartmann, R. W., Recanatini, M.. Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach. Journal of Medicinal Chemistry. 2005; 48 (23): 7282-7289

    Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., Korach, K. S.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine. 1994; 331 (16): 1056-1061

    Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., Qin, K.. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism. 1995; 80 (12): 3689-3698

    Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., Simpson, E. R.. Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine. 1997; 337 (2): 91-95

    Hero, M., Norjavaara, E., Dunkel, L.. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism. 2005; 90 (12): 6396-6402

    Shulman, D. I., Francis, G. L., Palmert, M. R., Eugster, E. A.. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics. 2008; 121 (4): e975-e983

  • Related Organizations (4)
  • Metrics
Share - Bookmark